Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Conference News TCT 2021

iFR Matches FFR Through 5 Years: iFR-SWEDEHEART

Caitlin E. Cox

November 04, 2021

Presentation TCT 2021

TCT 629: Coronary Thrombosis in the Context of Covid-19 and The Use of OCT to Guide Management

Presenter: Luiz Felipe Carvalho Lopes

November 04, 2021

News Daily News

IVUS-Guided PCI Tied to Better Long-term Outcomes After Acute MI

Todd Neale

October 29, 2021

News Conference News TCT 2021

Good Long-term Results With FANTOM BVS, but More Data Needed

Michael O'Riordan

October 21, 2021

News Daily News

Cardiac Deaths and Adverse Events After PCI Have Declined With Time

L.A. McKeown

October 05, 2021

News Opinion CV Team Dispatch

October 2021 News Roundup

L.A. McKeown

October 01, 2021

News Daily News

In Adults, CV Pathology Dominates COVID-19 Multisystem Inflammatory Syndrome

Shelley Wood

September 23, 2021

News Conference News ACC 2021

FFR Doesn’t Beat Angio for Complete Revasc in STEMI: FLOWER-MI

Caitlin E. Cox

May 25, 2021

News Conference News EuroPCR 2021

Provisional Stenting Noninferior to Planned Two-Stent Strategy for Left Main Disease: EBC MAIN

L.A. McKeown

May 21, 2021

News Conference News EuroPCR 2021

FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold

Michael O'Riordan

May 19, 2021

News Conference News ACC 2021

Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC

Michael O'Riordan

May 17, 2021

News Daily News

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Michael O'Riordan

April 23, 2021

News Daily News

Papers Confirm Rare Thrombocytopenia Link to AstraZeneca Vaccine

Shelley Wood

April 09, 2021

News Daily News

Invasive Approach Best for Cocaine-Linked NSTEMI, but DAPT Is Key

Michael O'Riordan

March 16, 2021

News Daily News

Antiplatelets, Especially Cilostazol, Helpful in Moyamoya Arteriopathy

Michael O'Riordan

February 26, 2021

News Daily News

Primary PCI Underused but Just as Effective in Cancer Patients With STEMI

Michael O'Riordan

February 04, 2021

Advertisement

iFR Matches FFR Through 5 Years: iFR-SWEDEHEART

TCT 629: Coronary Thrombosis in the Context of Covid-19 and The Use of OCT to Guide Management

IVUS-Guided PCI Tied to Better Long-term Outcomes After Acute MI

Good Long-term Results With FANTOM BVS, but More Data Needed

Cardiac Deaths and Adverse Events After PCI Have Declined With Time

October 2021 News Roundup

In Adults, CV Pathology Dominates COVID-19 Multisystem Inflammatory Syndrome

FFR Doesn’t Beat Angio for Complete Revasc in STEMI: FLOWER-MI

Provisional Stenting Noninferior to Planned Two-Stent Strategy for Left Main Disease: EBC MAIN

FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold

Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Papers Confirm Rare Thrombocytopenia Link to AstraZeneca Vaccine

Invasive Approach Best for Cocaine-Linked NSTEMI, but DAPT Is Key

Antiplatelets, Especially Cilostazol, Helpful in Moyamoya Arteriopathy

Primary PCI Underused but Just as Effective in Cancer Patients With STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content